Latest

Jun 10, 2016
Sharing un-redacted inspection reports between FDA and EMA may reduce duplicate inspections of facilities.
Jun 06, 2016
There’s a stampede to relate prices to broader health benefits, but little consensus on how to do so, writes Jill Wechsler.
Jun 03, 2016
By Pharmaceutical Executive Editors
Policy makers "simply are not taking seriously the corrosive effect of corruption", study says.
May 31, 2016
For those willing to invest in the right capabilities, offering patient services can give pharma companies a tremendous opportunity.
May 20, 2016
Pharmaceutical Executive
Pharm Exec’s 10th annual Brand of the Year has raced into the lead position in the treatment-shifting immuno-oncology space.
May 17, 2016
GDP is seeing ‘track and trace’ becoming indispensable for drug product integrity. Interactive Response Technologies may offer a potential solution.
May 16, 2016
Payers, providers, patients and pharma companies all want to understand the value of specific treatments – and patient registries can help them do that.
May 02, 2016
As companies look to raise capital, selling and then leasing back real estate is a tempting option and one that other industries are utilizing, writes Karen Williamson.
Apr 26, 2016
The liver disease NASH has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market.
Apr 15, 2016
Pharmaceutical Executive
Pharm Exec profiles Roche’s Jennifer Cook, this year’s winner of the Healthcare Businesswomen’s Association (HBA) Woman of the Year award.
native1_300x100
lorem ipsum